Walter Reed and HIFU

Walter Reed Army Medical Center is the latest to join several academic centers for a clinical trial investigating the safety and efficacy of High Intensity Focused Ultrasound (HIFU) using the Sonablate(R) 500 for the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT). The technology is a minimally invasive, outpatient procedure using a transrectal probe to focus ultrasound energy resulting in a rise in the heat within the prostate, causing destruction of prostatic tissue. In a small U.S. safety trial, 91 percent of study participants treated had a negative biopsy at six months. Eligible participants must be between the ages of 40 and 80, and have biopsy confirmed local recurrence two or more years following external beam radiation failure, in addition to meeting other selection criteria.

Progress continues to be made in treating prostate cancer.

Have a good Wednesday.
Blessings,
Rick